review on glp-1 agonists and psychiatric effects The expanding role of receptor agonists: a narrative of current evidence future directions Clinical review of how glucagon-like
Description
Are there any specific dietary considerations when using GLP-1 analogues
Sotk, M., Clark, M., Suur, B
Diabetes is a chronic disease requiring ongoing management
1993Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain
What are the adverse effects I need to be aware of
They are different treatments with different risk profiles
